Riltrava Aerosphere Euroopa Liit - taani - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Budesonide "Stada" 0,25 mg/ml inhalationsvæske til nebulisator, suspension Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

budesonide "stada" 0,25 mg/ml inhalationsvæske til nebulisator, suspension

stada arzneimittel ag - budesonid - inhalationsvæske til nebulisator, suspension - 0,25 mg/ml